Energized
Berberis aristata.Built to break through.
An energized Berberine ingredient created to address the absorption limitations of conventional berberine for next-generation metabolic formulations — while its native alkaloid profile stays intact.
What do you need? Pick one · 30 seconds
97% berberine HCl, native profile unchanged.
Energization enhances absorption without altering berberine’s phytochemical identity.
Why?
BerberineQA™ is a potent plant alkaloid known for its wide-ranging benefits, from supporting blood glucose and lipid balance to gut health and metabolic resilience. Yet despite its promise, berberine suffers from notoriously poor bioavailability. This is due to its low water solubility and rapid metabolism by intestinal and hepatic enzymes.
How?
Quantum Ayurveda at Greenspace Herbs infuses select Ayurvedic ingredients with a controlled energy load, then locks that energy in a metastable form so it stays “primed” until it meets the body. BerberineQA™ is an energized, highly bioavailable ingredient developed to address this issue.
Pharmacokinetic study of BerberineQA™
- Randomized
- Open-label
- Single-dose
- Crossover
- 24 healthy volunteers
- Single 500 mg oral dose
- vs Standard Berberine extract
Peak level in bloodCmax
Total exposureAUC₀–∞
Time to peakTmax
Half-lifet½
BerberineQA™Standard BerberineBars to scale within each row · Time to peak: shorter is faster
SourceTahira HS, Khasim MTI (2026). Pharmacokinetic study of BerberineQA™ versus standard berberine extract in healthy humans: an open label, randomized single-dose, crossover study. Journal of Ayurveda and Integrated Medical Sciences, 11(4): 71–76. doi:10.21760/jaims.11.4.11
Want the full study on your desk?The clinical data, sent to you directly.
- Clean-label positioning
- Metabolic balance positioning
- Cardiometabolic support
- Faster systemic exposure
- Extended presence vs. standard berberine
The buyer takeawayHigher exposure and longer persistence — and a clean label to match. A strong premium-ingredient story for brands competing in the metabolic wellness category.
Published, completed, and still going.
Pharmacokinetic study of BerberineQA™ v/s standard berberine extract in healthy humans: an open-label, randomized, single-dose crossover study.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS), 2026; 11(4): 71–76 · Scopus indexedComparative Evaluation of BerberineQA™ and Standard Berberine Extract for Digestive Enzyme Inhibition: An In-vitro Study.
Int. Journal of Pharmaceutical Sciences and Drug Research (IJPSDR), 2026; 18(4): 178–183 · Scopus indexedAcute oral toxicity study (OECD 423).
90-day repeated-dose oral toxicity and efficacy study (OECD 408).
quality


Ready to formulate with more?
Claims and regulatory suitability should be reviewed for each target market and finished-product application.

